phosphatidylcholines has been researched along with Idiopathic Parkinson Disease in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (27.27) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Canale, C; Canepa, E; Dante, S; Diaspro, A; Jadavi, S; Relini, A | 1 |
| Dean, NJ; Dzamko, N; Galper, J; Halliday, GM; Kim, WS; Lewis, SJG; Pickford, R | 1 |
| Arita, T; Fujino, T; Fukata, M; Kono, S; Maruyama, T; Mawatari, S | 1 |
| Drakulić, D; Ilić, TV; Miletić Vukajlović, J; Pejić, S; Petković, M; Schiller, J; Stefanović, A | 1 |
| Broersen, K; Davletov, B; Ruiperez, V | 1 |
| Amoussouvi, A; Haralampiev, I; Herrmann, A; Stöckl, M; Wietek, J | 1 |
| Banerjee, R; Carvalho, E; Dwivedi, S; Ghosh, D; Kumar, A; Maji, SK; Mohite, GM; Ranjan, P; Sahay, S; Salot, S; Singh, PK | 1 |
| Claessens, MM; Lindhoud, S; Semerdzhiev, SA; Stefanovic, AN; Subramaniam, V | 1 |
| Farmer, K; Hayley, S; Smith, CA; Smith, J | 1 |
| Calzada, E; Claypool, SM; Onguka, O | 1 |
| Barron, A; Caldwell, GA; Caldwell, KA; Galiano, F; Lee, YJ; Patel, D; Wang, S; Witt, SN; Xu, C; Zhang, S | 1 |
| Cheng, H; Han, X; McKeel, DW; Xu, J | 1 |
| Bussell, R; Eliezer, D | 1 |
| Brosnan, JT; Brosnan, ME; Jacobs, RL; Stead, LM | 1 |
| Fischer, P; Herrmann, A; Stöckl, M; Wanker, E | 1 |
| Samorukov, AE | 1 |
| Garcia, CA; Tweedy, JR | 1 |
| Barbeau, A | 1 |
| Ding, TT; Kessler, JC; Lansbury, PT; Lee, SJ; Rochet, JC; Shtilerman, MD; Volles, MJ | 1 |
| Pelliniemi, TT; Riekkinen, P; Rinne, UK; Sonninen, V | 1 |
| Leathwood, PD | 1 |
| Oleĭnik, LI; Poliukhov, AM; Vaĭnshtok, AB | 1 |
3 review(s) available for phosphatidylcholines and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Phosphatidylethanolamine Metabolism in Health and Disease.
Topics: Alzheimer Disease; Animals; Autophagy; Candida; Carboxy-Lyases; Cell Membrane; Cytidine Diphosphate; Ethanolamines; Humans; Lipid Metabolism; Methylation; Mitochondria; Non-alcoholic Fatty Liver Disease; Oxidative Phosphorylation; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Prions; Protein Processing, Post-Translational; Virulence | 2016 |
Methylation demand: a key determinant of homocysteine metabolism.
Topics: Animals; Creatine; Guanidinoacetate N-Methyltransferase; Homocysteine; Humans; Levodopa; Methylation; Methyltransferases; Models, Biological; Models, Chemical; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamine N-Methyltransferase; Rats | 2004 |
Lecithin in Parkinson's disease.
Topics: Humans; Intelligence Tests; Parkinson Disease; Phosphatidylcholines | 1980 |
1 trial(s) available for phosphatidylcholines and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Lecithin treatment of cognitively impaired Parkinson's patients.
Topics: Aged; Cognition Disorders; Double-Blind Method; Humans; Parkinson Disease; Phosphatidylcholines; Random Allocation | 1982 |
18 other study(ies) available for phosphatidylcholines and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
α-Synuclein interacts differently with membranes mimicking the inner and outer leaflets of neuronal membranes.
Topics: alpha-Synuclein; Biomimetics; Cell Membrane; Cytoplasm; Humans; Membrane Lipids; Neurons; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamines | 2022 |
Lipid pathway dysfunction is prevalent in patients with Parkinson's disease.
Topics: alpha-Synuclein; Biomarkers; Ceramides; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulins; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Parkinson Disease; Phosphatidylcholines; Sphingomyelins; Triglycerides | 2022 |
Decreases of ethanolamine plasmalogen and phosphatidylcholine in erythrocyte are a common phenomenon in Alzheimer's, Parkinson's, and coronary artery diseases.
Topics: Alzheimer Disease; Coronary Artery Disease; Erythrocyte Membrane; Humans; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamines; Plasmalogens; Sphingomyelins | 2022 |
Increased plasma phosphatidylcholine/lysophosphatidylcholine ratios in patients with Parkinson's disease.
Topics: Aged; Case-Control Studies; Female; Humans; Lysophosphatidylcholines; Male; Middle Aged; Parkinson Disease; Phosphatidylcholines; Plasma; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2020 |
Structural and Aggregation Properties of Alpha-Synuclein Linked to Phospholipase A2 Action.
Topics: alpha-Synuclein; Animals; Arachidonic Acid; Fatty Acid-Binding Proteins; Fluorescent Dyes; Humans; Liposomes; Mice; Oxidation-Reduction; Parkinson Disease; Phosphatidylcholines; Phospholipases A2; Protein Aggregates; Protein Conformation; RAW 264.7 Cells; Recombinant Proteins | 2018 |
Membrane bound α-synuclein is fully embedded in the lipid bilayer while segments with higher flexibility remain.
Topics: Acrylamide; alpha-Synuclein; Amino Acid Sequence; Cell Membrane; Humans; Lipid Bilayers; Lipids; Micelles; Molecular Sequence Data; Parkinson Disease; Phosphatidylcholines; Phosphatidylserines; Protein Binding; Protein Structure, Tertiary; Tryptophan | 2013 |
The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates α-synuclein aggregation and membrane binding.
Topics: alpha-Synuclein; Amino Acid Substitution; Amyloid; Circular Dichroism; Finland; Fluorescent Dyes; Humans; Kinetics; Lipid Bilayers; Microscopy, Atomic Force; Mutation; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamines; Protein Aggregation, Pathological; Protein Structure, Secondary; Recombinant Proteins; Spectrometry, Fluorescence; Surface Plasmon Resonance; Surface Properties | 2014 |
Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
Topics: alpha-Synuclein; Cell Membrane Permeability; Fluoresceins; Humans; Membranes, Artificial; Multiprotein Complexes; Mutation, Missense; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylglycerols; Protein Binding; Scattering, Small Angle; X-Ray Diffraction | 2015 |
Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease.
Topics: Animals; Disease Models, Animal; Humans; Lipid Metabolism; Lysophosphatidylcholines; Male; Parkinson Disease; Phosphatidylcholines; Rats; Substantia Nigra; Tandem Mass Spectrometry | 2015 |
Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carboxy-Lyases; Cyclosporine; Disease Models, Animal; Dopaminergic Neurons; Endoplasmic Reticulum Stress; Meclofenoxate; Membrane Proteins; Mitochondria; Mitochondrial Proteins; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamines; Protective Agents; Saccharomyces cerevisiae; Solubility; Sulfaphenazole; Transferases (Other Substituted Phosphate Groups) | 2016 |
Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Brain Chemistry; Cells, Cultured; Fatty Acids; Galactosylceramides; Humans; Lewy Body Disease; Lipids; Lithium Compounds; Oligodendroglia; Parkinson Disease; Peptide Fragments; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylglycerols; Phosphatidylinositols; Phosphatidylserines; Plasmalogens; Rats; Spectrometry, Mass, Electrospray Ionization; Sphingomyelins; Sulfoglycosphingolipids | 2003 |
Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein.
Topics: Alanine; alpha-Synuclein; Humans; Lipid Metabolism; Liposomes; Micelles; Mutation, Missense; Nerve Tissue Proteins; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Phosphatidic Acids; Phosphatidylcholines; Proline; Protein Binding; Protein Structure, Secondary; Recombinant Proteins; Synucleins; Threonine | 2004 |
Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.
Topics: alpha-Synuclein; Amino Acid Sequence; Anions; Binding Sites; Cell Membrane; Fatty Acids; Fluorescent Dyes; Hydrophobic and Hydrophilic Interactions; Lipids; Microscopy, Fluorescence; Molecular Sequence Data; Molecular Weight; Mutation; Parkinson Disease; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylglycerols; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylserines; Phospholipids; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Rhodamines; Static Electricity; Surface Properties; Unilamellar Liposomes | 2008 |
[Lipid metabolism disorders in parkinsonism and Huntington's chorea].
Topics: Adolescent; Adult; Aged; Brain Chemistry; Caudate Nucleus; Child; Cholesterol; Erythrocytes; Fatty Acids; Female; Glycerides; Humans; Huntington Disease; Lipids; Male; Middle Aged; Parkinson Disease; Phosphatidylcholines; Phospholipids; Substantia Nigra | 1980 |
Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease.
Topics: Adsorption; alpha-Synuclein; Cytotoxins; Humans; Lewy Bodies; Nerve Tissue Proteins; Parkinson Disease; Permeability; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylglycerols; Phospholipids; Protein Binding; Protein Structure, Secondary; Synucleins; Time Factors | 2001 |
Interaction between dopamine and phospholipids. Studies of the substantia nigra in Parkinson disease patients.
Topics: Aged; Autopsy; Carboxy-Lyases; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phosphatidylserines; Phospholipids; Sphingomyelins; Substantia Nigra | 1975 |
Neurotransmitter precursors and brain function.
Topics: Aged; Aging; Alzheimer Disease; Animals; Biological Transport; Brain; Diet; Humans; Learning; Levodopa; Memory; Neurotransmitter Agents; Parkinson Disease; Phosphatidylcholines; Serotonin; Sleep; Tryptophan | 1986 |
[The state of fat-lipid metabolism in atherosclerotic parkinsonism in old age (clinico-biochemical parallels)].
Topics: Aged; Blood Glucose; Cholesterol; Fatty Acids, Nonesterified; Humans; Intracranial Arteriosclerosis; Lipid Metabolism; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Parkinson Disease; Phosphatidylcholines; Triglycerides | 1970 |